Thinking of joining a study?

Register your interest

NCT06998966 | RECRUITING | Prescribing Patterns, Physician


Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support
Sponsor:

University of California, Los Angeles

Information provided by (Responsible Party):

John N. Mafi, MD, MPH

Brief Summary:

The proposed study is a quality improvement initiative designed to rigorously evaluate new variations of UCLA Health's proton pump inhibitor (PPI) order panels, building on internal quality improvement efforts to optimize prescribing workflows within the Electronic Health Record (EHR). PPIs are notoriously overprescribed, and the study team has identified that the CareConnect default prescription setting of 90 days with three refills (360 pill days) exceed standard guidelines (in most cases, 60 pill days). It is unclear whether this is the most appropriate workflow. Given that deprescribing PPIs carries minimal risk for most patients, this initiative will assess whether modifying defaulted prescription lengths influences prescribing behavior while ensuring physicians retain full decision-making authority. This evaluation of PPI order panel variations is embedded within UCLA's existing EHR system, ensuring that changes are tested pragmatically within routine workflows. The study aims to determine whether small adjustments to the order panel can better align prescribing patterns with clinical best practices while maintaining physician autonomy.

Condition or disease

Prescribing Patterns, Physician

Physician's Practice Patterns

Drug Utilization Review

Intervention/treatment

Algorithmic Defaulting (Indication-Based Default)

Active Physician Choice

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 372 participants
Masking : DOUBLE
Primary Purpose : HEALTH_SERVICES_RESEARCH
Official Title : Quality Improvement Initiative Leveraging Electronic Healthcare Records to Reduce Inappropriate Proton Pump Inhibitors (PPI) Prescribing at UCLA.
Actual Study Start Date : 2026-01
Estimated Primary Completion Date : 2026-11
Estimated Study Completion Date : 2027-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 50 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * UCLA Health primary care physicians who have a clinical full-time equivalency of at least 25%.
Exclusion Criteria
  • * Physicians with a clinical full-time equivalency of less than 25%

Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support

Location Details

NCT06998966


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, California

UCLA Health System

Los Angeles, California, United States, 90024

Loading...